Alexandria Real Estate Equities
ARE
#2319
Rank
โ‚ฌ6.75 B
Marketcap
39,06ย โ‚ฌ
Share price
-2.38%
Change (1 day)
-58.40%
Change (1 year)
Alexandria Real Estate Equities, Inc. is a real estate investment trust that invests in office buildings and laboratories.

Earnings for Alexandria Real Estate Equities (ARE)

Earnings in 2025 (TTM): -โ‚ฌ6.92 Million

According to Alexandria Real Estate Equities 's latest financial reports the company's current earnings are โ‚ฌ2.97 Billion. In 2024 the company made an earning of โ‚ฌ0.59 Billion, an increase over its 2023 earnings that were of โ‚ฌ0.30 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Alexandria Real Estate Equities from 2013 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ6.92 Million-101.15%
2024 โ‚ฌ0.59 B96.11%
2023 โ‚ฌ0.30 B-53.56%
2022 โ‚ฌ0.65 B-3.96%
2021 โ‚ฌ0.68 B-20.26%
2020 โ‚ฌ0.85 B72.88%
2019 โ‚ฌ0.49 B3.11%
2018 โ‚ฌ0.48 B73.54%
2017 โ‚ฌ0.27 B464.88%
2016 โ‚ฌ49.08 M-77.32%
2015 โ‚ฌ0.21 B36.31%
2014 โ‚ฌ0.15 B-10.81%
2013 โ‚ฌ0.17 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚ฌ10.17 B-57,124.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚ฌ8.49 B-47,665.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚ฌ19.32 B-108,373.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ0.85 B-4,887.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚ฌ6.89 B-38,749.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
โ‚ฌ7.08 B-39,765.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ0.11 B-727.01%๐Ÿ‡บ๐Ÿ‡ธ USA